imtadvances.bsky.social
#OpenAccess journal covering the translational pipeline for #immunotherapy 🎯Included in WoS, PubMed & Scopus
👤 Joined on 23 September 2024
Followers
Following
Total Posts
@imtadvances.bsky.socialToday is the early bird registration and poster presentation submission deadline for #BSICIPN26. If you’re planning to join us in Glasgow on 30 Nov & 1 Dec, today is the last chance to register and save! We’d love to see you there. Register: vist.ly/5pajz
Show PostToday is #WorldPatientSafetyDay, focusing this year on safe care for noncommunicable diseases. Sary Workman reflects on how research has improved her practice and helps ensure patients receive current, evidence-based care. 🎥 www.immunology.org/research-cli... #PatientSafety #SafeCareForLife
Show PostDiscover the benefits available when peer reviewing for the @britsocimm.bsky.social journals, including a chance to work with immunology experts to advance research. 🔗 oxford.ly/4fWq6kZ #ImmunoSky | @ceijournal.bsky.social | @imtadvances.bsky.social | @discovimmunol.bsky.social
Show PostDiscover benefits available when you become a peer reviewer for the @britsocimm.bsky.social journals, including a chance work with immunology experts to advance research. 🔗 oxford.ly/4sz3vPa #ImmunoSky @ceijournal.bsky.social @imtadvances.bsky.social @discovimmunol.bsky.social
Show PostSupport @imtadvances.bsky.social in advancing immunotherapies for neurodegenerative & CNS immune-mediated diseases. We welcome original research, reviews, and clinical trial protocols on therapeutic development in neuroimmunology: oxford.ly/4pBKPwp #ImmunoSky #Immunotherapy
Show Post